Perform Another (Advanced) Search

1.  Study Posting (168) Trial #75326, Eye Disorders/Infections, Hollywood, FL
...Posting (168) Trial #75326, Eye Disorders/Infections, Hollywood, FL Trial Information Patients suffering from ophthalmic adenovirus A Multi-site, Randomized, Multiple Dose, Double-Blind Study of Topical Ophthalmic CTC 96 in Adenovirus Infected Volunteers. For more information, Sheila Hirsch Horizon Institute for Clinical Research 3990 Sheridan St ...
View Page

2.  Study Posting (2348) Trial #56502, Prostate Cancer, New York, NY
...Posting (2348) Trial #56502, Prostate Cancer, New York, NY Trial Information Phase I Trial of Adenovirus- Mediated IL-12 Gene Transduction in Patients with Radiorecurrent Prostate Cancer The purpose of this ...
...org View Google Map support@centerwatch.com cynthia.knauer@mountsinai.org Phase I Trial of Adenovirus- Mediated IL-12 Gene Transduction in Patients with Radiorecurrent Prostate Cancer Prostate Cancer New York ...
View Page

3.  Study Posting (2348) Trial #50075, Liver Metastases, New York, NY
...liver is performed at the same time to track the needles in the liver. An adenovirus (ADV-hIL12) which has been genetically altered so that it cannot reproduce itself and produce ...
...is performed under local anesthesia. In animal studies a single intratumoral injection of the altered adenovirus induced a strong anti-tumor immune response which led to tumor regression at metastatic sites ...
View Page

4.  Study Posting (2472) Trial #106944, Pancreatic Cancer, Milwaukee, WI
...as first-line treatment of unresectable locally advanced pancreatic cancer. TNFerade™ is a replication deficient adenovirus vector containing the gene for TNF-alpha controlled by a chemoradiation inducible promoter. This allows ...
View Page

5.  Study Posting (2472) Trial #106940, Pancreatic Cancer, Washington, DC
...as first-line treatment of unresectable locally advanced pancreatic cancer. TNFerade™ is a replication deficient adenovirus vector containing the gene for TNF-alpha controlled by a chemoradiation inducible promoter. This allows ...
View Page

6.  Study Posting (2472) Trial #118137, Pancreatic Cancer, Seattle, WA
...as first-line treatment of unresectable locally advanced pancreatic cancer. TNFerade™ is a replication deficient adenovirus vector containing the gene for TNF-alpha controlled by a chemoradiation inducible promoter. This allows ...
View Page

7.  Study Posting (2472) Trial #106927, Pancreatic Cancer, Richmond, VA
...as first-line treatment of unresectable locally advanced pancreatic cancer. TNFerade™ is a replication deficient adenovirus vector containing the gene for TNF-alpha controlled by a chemoradiation inducible promoter. This allows ...
View Page

8.  Study Posting (2472) Trial #106939, Pancreatic Cancer, Houston, TX
...as first-line treatment of unresectable locally advanced pancreatic cancer. TNFerade™ is a replication deficient adenovirus vector containing the gene for TNF-alpha controlled by a chemoradiation inducible promoter. This allows ...
View Page

9.  Study Posting (2472) Trial #120688, Pancreatic Cancer, Dallas, TX
...as first-line treatment of unresectable locally advanced pancreatic cancer. TNFerade™ is a replication deficient adenovirus vector containing the gene for TNF-alpha controlled by a chemoradiation inducible promoter. This allows ...
View Page

10.  Study Posting (2472) Trial #106923, Pancreatic Cancer, Dallas, TX
...as first-line treatment of unresectable locally advanced pancreatic cancer. TNFerade™ is a replication deficient adenovirus vector containing the gene for TNF-alpha controlled by a chemoradiation inducible promoter. This allows ...
View Page

11.  Study Posting (2472) Trial #106943, Pancreatic Cancer, Greenville, SC
...as first-line treatment of unresectable locally advanced pancreatic cancer. TNFerade™ is a replication deficient adenovirus vector containing the gene for TNF-alpha controlled by a chemoradiation inducible promoter. This allows ...
View Page

12.  Study Posting (2472) Trial #130170, Pancreatic Cancer, Greenville, NC
...as first-line treatment of unresectable locally advanced pancreatic cancer. TNFerade™ is a replication deficient adenovirus vector containing the gene for TNF-alpha controlled by a chemoradiation inducible promoter. This allows ...
View Page

13.  Study Posting (2472) Trial #118138, Pancreatic Cancer, New York, NY
...as first-line treatment of unresectable locally advanced pancreatic cancer. TNFerade™ is a replication deficient adenovirus vector containing the gene for TNF-alpha controlled by a chemoradiation inducible promoter. This allows ...
View Page

14.  Study Posting (2472) Trial #106931, Pancreatic Cancer, St. Louis, MO
...as first-line treatment of unresectable locally advanced pancreatic cancer. TNFerade™ is a replication deficient adenovirus vector containing the gene for TNF-alpha controlled by a chemoradiation inducible promoter. This allows ...
View Page

15.  Study Posting (2472) Trial #141689, Pancreatic Cancer, Kansas City, MO
...as first-line treatment of unresectable locally advanced pancreatic cancer. TNFerade™ is a replication deficient adenovirus vector containing the gene for TNF-alpha controlled by a chemoradiation inducible promoter. This allows ...
View Page

16.  Study Posting (2472) Trial #130169, Pancreatic Cancer, Detroit, MI
...as first-line treatment of unresectable locally advanced pancreatic cancer. TNFerade™ is a replication deficient adenovirus vector containing the gene for TNF-alpha controlled by a chemoradiation inducible promoter. This allows ...
View Page

17.  Study Posting (2472) Trial #130168, Pancreatic Cancer, Boston, MA
...as first-line treatment of unresectable locally advanced pancreatic cancer. TNFerade™ is a replication deficient adenovirus vector containing the gene for TNF-alpha controlled by a chemoradiation inducible promoter. This allows ...
View Page

18.  Study Posting (2472) Trial #106947, Pancreatic Cancer, Baltimore, MD
...as first-line treatment of unresectable locally advanced pancreatic cancer. TNFerade™ is a replication deficient adenovirus vector containing the gene for TNF-alpha controlled by a chemoradiation inducible promoter. This allows ...
View Page

19.  Study Posting (2472) Trial #133274, Pancreatic Cancer, Indianapolis, IN
...as first-line treatment of unresectable locally advanced pancreatic cancer. TNFerade™ is a replication deficient adenovirus vector containing the gene for TNF-alpha controlled by a chemoradiation inducible promoter. This allows ...
View Page

20.  Study Posting (2472) Trial #111019, Pancreatic Cancer, Olympia Fields, IL
...as first-line treatment of unresectable locally advanced pancreatic cancer. TNFerade™ is a replication deficient adenovirus vector containing the gene for TNF-alpha controlled by a chemoradiation inducible promoter. This allows ...
View Page